Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Relief for online...

    Relief for online pharmacy traders: Madras High Court vacates stay on sale of online drugs

    Farhat NasimWritten by Farhat Nasim Published On 2019-01-03T13:41:15+05:30  |  Updated On 2021-08-16T12:09:51+05:30

    Chennai: A sigh of relief comes for the online pharmacy traders and patients purchasing drugs via online pharmacies after the Madras High Court vacated an interim stay passed by it against online sale of drugs.


    The interim stay order was passed by Justice R Mahadevan on a plea moved by Tamil Nadu Chemists & Druggists Association and was to be observed till the central government notified rules regulating the trade.


    The court at the same had directed the Central government to come up with draft rules for the online sale of drugs by 31 January.


    Also Read: Madras High Court refuses to set aside stay on online sale of drugs


    In the recent hearing a division bench of Justice M Sathyanarayanan and P Rajamanickam has set aside the interim stay paying heed to the needy patients.


    "If all of a sudden, it is stopped till the amendments are notified, it would definitely create grave hardship, inconvenience and health issues to the concerned patients or persons, who order medicines through online platform," it said.

    Medical Dialogues had earlier reported,the petitioner had filed a writ petition seeking a direction to the respondents to block the link of all such websites who are carrying online sale of Schedule H, H1 & Schedule X medicines in violation of Rule 65 & 97 of the Drugs and Cosmetics Rules, 1945, till the licences are granted to sell medicines through online.

    According to the association, though online shopping might be convenient to consumers, purchasing medicines from unlicensed online stores can be risky as they may sell fake, expired, contaminated, unapproved drugs or otherwise unsafe products that are dangerous to patients and which might put their health at risk.

    "Moreover, laws for pharmacies in India are derived from the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rule, 1945 and the Pharmacy Act, 1948. These laws were written prior to the arrival of computers and India does not have any concrete laws defined for the online sale of medicines. Though various amendments had been made to the Acts, no provision had been incorporated to utilize information technology for sale of medicines online," the association told the daily.


    "Medicines are not simple items of commerce, they are an essential component of patients' health and they must be administrated to patients in a timely manner as prescribed by a registered medical practitioner and such drugs are provided under the direct supervision of a qualified pharmacist for the benefit of patients," it added.


    Also Read: No online sale of drugs till regulatory rules in place: Delhi High Court


    Responding to the petition, the online traders also moved an appeal in the high court. They opposed the association's plea contending that such sale was legal as many of them held valid licences.


    They further added that others were just a website or program that collected related items of content and displayed or linked to them, acting as couriers for licensed pharmacies.


    The online pharmacies also asserted that the Centre had framed draft rules to govern such online sale and the same would be notified soon.


    The bench adjourned the appeals for final hearing on January 24.
    1948 Central Government Chennai Drugs and Cosmetics Act Drugs and Cosmetics Act 1940 Drugs and Cosmetics Rule drugs and cosmetics rule 1945 e-pharmacies e-pharmacy Justice M Sathyanarayanan Justice R Mahadevan Madras High Court online drugs online medicines Online Pharmacy P Rajamanickam pharma Pharma companies pharma companies in Bangalore pharma companies in India Pharma Industry Pharma industry in india pharma news india pharma vacancy Pharmacy Act Tamil Nadu Chemists & Druggists Association top phar 
    Source : With input

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      After Abbott, two more Stent makers seek withdrawal of New Gen Stents

      After Abbott, two more Stent makers seek withdrawal of New Gen Stents

      3.36% of about 82,600 drugs samples found to be substandard

      3.36% of about 82,600 drugs samples found to be substandard

      Sterling Biotech Bank Fraud: ED seize assets including business jet, ships, oil rings worth over Rs 9700 crore

      Sterling Biotech Bank Fraud: ED seize assets including business jet, ships, oil rings worth over Rs...

      Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial

      Johnson and Johnson must pay 4 million dollar in punitive damages in latest asbestos cancer trial

      Apollo medical centre in Oman granted hospital status

      Apollo medical centre in Oman granted hospital status

      Calcutta HC sets aside Centers decision for strategic sale of Bengal Chemicals

      Calcutta HC sets aside Center's decision for strategic sale of Bengal Chemicals

      Johnson n Johnson ties up with CSIR-IMTECH to Develop Innovative Tuberculosis Treatments

      Johnson n Johnson ties up with CSIR-IMTECH to Develop Innovative Tuberculosis Treatments

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      Johnson & Johnson Risperdal Lawsuit: US Court Slashes USD 8 Billion Verdict

      View All

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 27 May 2022 6:45 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
      verify here.

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
      X
      X